Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02725489
Title Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mary Crowley Medical Research Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.